워싱턴의 크론병 임상 시험
크론병 관련 연구 22개가 워싱턴 내 여러 지역에서 참여자를 모집하고 있습니다.
워싱턴의 도시
공식 연구 텍스트(영어)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- Washington Gastroenterology - Tacoma ( Site 0295), Tacoma
피험자 모집 중3상
전 연령 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06651281A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Washington ( Site 5115), Seattle
- Washington Gastroenterology - Tacoma ( Site 5004), Tacoma
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Washington Gastroenterology - Bellevue /ID# 283966, Bellevue
- Washington Gastroenterology - Tacoma /ID# 284143, Tacoma
- The Vancouver Clinic /ID# 280497, Vancouver
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- GI Alliance, Bellevue
피험자 모집 중4상
18세 ~ 80세 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Virginia Mason Hospital and Medical Center /ID# 265574, Seattle
- Washington Gastroenterology - Tacoma /ID# 267302, Tacoma
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06548542A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance Tacoma, Tacoma
피험자 모집 중2/3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University of Washington Medical Center, Seattle
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Washington Gastroenterology - Tacoma, Tacoma
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 9. 24. 업데이트됨 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance - Bellevue-Site Number: 8400143, Bellevue
- The Vancouver Clinic Inc. P.S.-Site Number: 8400090, Vancouver
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- The Vancouver Clinic Inc. P.S.-Site Number: 8400090, Vancouver
피험자 모집 중3상
16세 ~ 80세 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07184944A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Washington Gastroenterology- GIA, Tacoma
피험자 모집 중4상
18세 ~ 70세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06045754Familial Inflammatory Bowel Disease Early Risk
- Seattle Children's Hospital, Seattle
피험자 모집 중관찰 연구건강한 지원자 환영
0세 ~ 55세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07791862A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- GI Alliance Tacoma, Tacoma
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07577843A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Seattle Children's Hospital, Seattle
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05509777A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- MultiCare Institute for Research & Innovation, Tacoma
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Multicare Health System Institute for Research and Innovation, Tacoma
피험자 모집 중3상
2세 ~ 17세 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06405087Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Seattle Children's Hospital, Seattle
피험자 모집 중4상
6세 ~ 17세 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT05781152A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease
- Swedish Cancer Institute, Seattle
- University of Washington Medical Center - Montlake, Seattle
피험자 모집 중3상
18세 ~ 65세 · 모든 성별 · 2026. 5. 27. 업데이트됨 · NCT06227910Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- University of Washington, Seattle
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 4. 27. 업데이트됨 · NCT06456593Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)
- Seattle Children's Hospital, Seattle
피험자 모집 중관찰 연구
6세 ~ 21세 · 모든 성별 · 2026. 4. 24. 업데이트됨 · NCT06315179A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Bellevue
- Mirador Therapeutics Selected Site, Silverdale
- Mirador Therapeutics Selected Site, Tacoma
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 3. 12. 업데이트됨 · NCT07113522Reverse-Engineering of Exclusive Enteral Nutrition (RE-EEN) in Crohn's Disease: A Multi-Center Trial
- Seattle Children's Hospital, Seattle
피험자 모집 중
8세 ~ 21세 · 모든 성별 · 2025. 6. 12. 업데이트됨 · NCT06216899ClinicalTrials.gov 출처, 2026. 10. 5. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.